# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-246317
Filing Date
2020-09-15
Accepted
2020-09-15 17:20:59
Documents
22
Period of Report
2020-09-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d10968d6k.htm | 6-K | 33958
2 | GRAPHIC | g10968img001.jpg | GRAPHIC | 20335
3 | GRAPHIC | g10968txs10g1.jpg | GRAPHIC | 319453
4 | GRAPHIC | g10968txs11g1.jpg | GRAPHIC | 256206
5 | GRAPHIC | g10968txs12g1.jpg | GRAPHIC | 270331
6 | GRAPHIC | g10968txs13g1.jpg | GRAPHIC | 324675
7 | GRAPHIC | g10968txs14g1.jpg | GRAPHIC | 206365
8 | GRAPHIC | g10968txs15g1.jpg | GRAPHIC | 287638
9 | GRAPHIC | g10968txs16g1.jpg | GRAPHIC | 270438
10 | GRAPHIC | g10968txs17g1.jpg | GRAPHIC | 187040
11 | GRAPHIC | g10968txs18g1.jpg | GRAPHIC | 286736
12 | GRAPHIC | g10968txs19g1.jpg | GRAPHIC | 207623
13 | GRAPHIC | g10968txs20g1.jpg | GRAPHIC | 288897
14 | GRAPHIC | g10968txs21g1.jpg | GRAPHIC | 222307
15 | GRAPHIC | g10968txs22g1.jpg | GRAPHIC | 274739
16 | GRAPHIC | g10968txs23g1.jpg | GRAPHIC | 70732
17 | GRAPHIC | g10968txs4g1.jpg | GRAPHIC | 218638
18 | GRAPHIC | g10968txs5g1.jpg | GRAPHIC | 317994
19 | GRAPHIC | g10968txs6g1.jpg | GRAPHIC | 215682
20 | GRAPHIC | g10968txs7g1.jpg | GRAPHIC | 258732
21 | GRAPHIC | g10968txs8g1.jpg | GRAPHIC | 209061
22 | GRAPHIC | g10968txs9g1.jpg | GRAPHIC | 355248
| Complete submission text file | 0001193125-20-246317.txt |  | 7018330

Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 201176776
SIC: 2834 Pharmaceutical Preparations